OPKO Health Inc (OPK)
1.315
+0.02
(+1.15%)
USD |
NASDAQ |
May 06, 13:24
OPKO Health Cash from Financing (Quarterly): -3.751M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.751M |
| September 30, 2023 | 2.105M |
| June 30, 2023 | 3.462M |
| March 31, 2023 | -13.12M |
| December 31, 2022 | 10.14M |
| September 30, 2022 | 8.444M |
| June 30, 2022 | 12.27M |
| March 31, 2022 | -7.891M |
| December 31, 2021 | 0.833M |
| September 30, 2021 | -4.255M |
| June 30, 2021 | 0.264M |
| March 31, 2021 | -7.192M |
| December 31, 2020 | 8.108M |
| September 30, 2020 | -54.46M |
| June 30, 2020 | 12.89M |
| March 31, 2020 | -1.611M |
| December 31, 2019 | 70.64M |
| September 30, 2019 | -20.00M |
| June 30, 2019 | -39.28M |
| March 31, 2019 | 163.88M |
| December 31, 2018 | 90.70M |
| September 30, 2018 | -3.005M |
| June 30, 2018 | 4.02M |
| March 31, 2018 | 49.19M |
| December 31, 2017 | 4.226M |
| Date | Value |
|---|---|
| September 30, 2017 | 22.90M |
| June 30, 2017 | 31.74M |
| March 31, 2017 | 2.174M |
| December 31, 2016 | 1.778M |
| September 30, 2016 | 0.96M |
| June 30, 2016 | -37.99M |
| March 31, 2016 | 0.053M |
| December 31, 2015 | -0.171M |
| September 30, 2015 | 14.69M |
| June 30, 2015 | 4.67M |
| March 31, 2015 | 13.81M |
| December 31, 2014 | 4.129M |
| September 30, 2014 | 7.135M |
| June 30, 2014 | 2.53M |
| March 31, 2014 | -6.531M |
| December 31, 2013 | 17.04M |
| September 30, 2013 | 2.813M |
| June 30, 2013 | -5.856M |
| March 31, 2013 | 169.64M |
| December 31, 2012 | 1.048M |
| September 30, 2012 | -1.774M |
| June 30, 2012 | 1.879M |
| March 31, 2012 | 4.878M |
| December 31, 2011 | -8.356M |
| September 30, 2011 | -0.146M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-54.46M
Minimum
Sep 2020
70.64M
Maximum
Dec 2019
-1.178M
Average
0.264M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Innerscope Hearing Technologies Inc | 0.6087M |
| Stryker Corp | -418.00M |
| Perspective Therapeutics Inc | 0.352M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.172M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -38.29M |
| Cash from Investing (Quarterly) | -1.418M |
| Free Cash Flow | -44.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0549 |
| Free Cash Flow to Equity (Quarterly) | -39.35M |
| Free Cash Flow to Firm (Quarterly) | -38.98M |
| Free Cash Flow Yield | -4.50% |